Regulatory guidance
CAMD MDR/IVDR Transition Subgroup: FAQ – MDR Transitional provisions
Published Jan 1, 2018
Reference
CAMD FAQ
Source
MDCG
Topic
Other guidance documents
Published
Jan 1, 2018
Languages
EN
© European Union — European Commission, DG SANTE. Reuse under CC BY 4.0.
Update on the guidelines on the benefit-risk assessment of the presence of phthalates in certain medical devicescovering phthalates which are carcinogenic, mutagenic, toxic to reproduction (CMR) or have endocrine-disrupting (ED) properties
Published Jun 1, 2024
Overview of language requirements for manufacturers of medical devices for the information and instructions that accompany a device in a specific country
Published Jan 1, 2024
Questions & Answers for applicants, marketing authorisation holders of medicinal products and notified bodies with respect to the implementation of the Medical Devices and In Vitro Diagnostic Medical Devices Regulations ((EU) 2017/745 and (EU) 2017/746)
Published Jun 1, 2021
Position Paper: UDI assignment between manufacturers and distributors
Published Jul 1, 2026